Navigation Links
Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
Date:5/29/2009

With all of the new treatments available for incontinence nowadays, an effective and easy solution is within reach for men and women struggling with incontinence. The main roadblock to that solution might just be the patient himself, by minimizing the severity of his condition. Dr. Peter Muench of Delaware Urologic Associates in Newark, Delaware, knows this all too well and advises patients that full disclosure is the best policy in helping them with their condition. Hopefully, with enough publicity about these advances in the treatment of both male and female incontinence, more patients will speak up and get their condition cured.

Newark, Delaware (PRWEB) May 29, 2009 -- In the past, a big fear for males undergoing either radical prostatectomy for prostate cancer or trimming for a blocking prostate (BPH) was urinary incontinence. Incontinence after radical prostatectomy will generally occur in about 2% of cases. Leakage after an over-aggressive trimming of a prostate for blockage occurs less often, but it's not unheard of.

Of course, the cases of male incontinence can vary by degrees depending on their perspective. After radical prostatectomy, men are often more willing to cope with their leakage than to undergo yet another procedure. A successful treatment is the American Medical Systems 800TM Urinary Control System, also known as an artificial urinary sphincter (AUS). It is the only artificial urinary sphincter currently on the market. For over 30 years, physicians worldwide have surgically implanted the device in more than 94,000 men as a treatment for stress [urinary incontinence due to prostatectomy.

However, many patients who leak mildly or moderately, using 1-4 pads per day, feel that an AUS is too invasive, because of the degree of their
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
2. Growth in Delaware Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study
3. Universal Capital Management Reports Top Delaware Surgeon to Join Advisory Board
4. Delaware Youth Shares Epilepsy Message on Capitol Hill
5. Silverman, McDonald & Friedman Opens New Office in New Castle to Serve Legal Needs of Delaware Families
6. HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference
7. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
8. AARP Survey Reveals Boomers Health Care Needs in Delaware
9. AARP Represents the Pulse of Delawareans 50+: Survey Reveals Attitudes about Health Care in Delaware
10. PA Department of Health Urges Sexually Active Individuals in Delaware County to Get STD Tests
11. Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 1Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 2Apollo PACS Inc Selected by Henry Ford Health System for Its Digital Pathology Solution 57359 3Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 1Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 2Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 3Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 4Health Leaders Issue Recommendations to Improve Management of a Common Costly and Misunderstood Cardiovascular Disease 3A Atrial Fibrillation 57357 5